FULGENT THERAPEUTICS
Fulgent Therapeutics was issued its CLIA license (CLIA 05D2043189/CLF 00342581). Apart from traditional single gene tests, Fulgent Therapeutics has been investing heavily in the future. Using Next Generation Sequencing (NGS) technology we are developing a new series of panel based tests for our clients.
FULGENT THERAPEUTICS
Industry:
Biotechnology Genetics Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Temple City, California, United States
Country:
United States
Website Url:
http://www.fulgentgenetics.com
Total Employee:
11+
Status:
Active
Contact:
626-350-0537
Email Addresses:
[email protected]
Total Funding:
34.83 M USD
Technology used in webpage:
SPF Global Site Tag Amazon Google Apps For Business Microsoft Azure DNS US Privacy User Signal Mechanism Amazon Route 53 Amazon Oregon Region KnowBe4
Similar Organizations
Baudax Bio
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
NewBridge Pharmaceuticals
Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.
Ocumension Therapeutics
Ocumension Therapeutics is a pharmaceutical platform dedicated to identifying, developing, and commercializing ophthalmic therapies.
Raptor Pharmaceuticals
Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics.
Rhythm Pharmaceuticals
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Santi Therapeutics
Santi Therapeutics is a pharmaceutical company that focuses on the research and development of small molecule therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-08-09 | CSI Laboratories | CSI Laboratories acquired by Fulgent Therapeutics | N/A |
| 2021-05-10 | FF Gene Biotech | FF Gene Biotech acquired by Fulgent Therapeutics | 19 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-23 | Spatial Genomics | Fulgent Therapeutics investment in Series A - Spatial Genomics | 56 M USD |
Official Site Inspections
http://www.fulgentgenetics.com Semrush global rank: 141.81 K Semrush visits lastest month: 619.02 K
- Host name: ec2-52-42-7-203.us-west-2.compute.amazonaws.com
- IP address: 52.42.7.203
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Fulgent Therapeutics"
About Us - Fulgent Genetics
[email protected]. Contact [email protected]. Locations Headquarters 4399 Santa Anita Ave El Monte, CA 91731 Phone: +1 (626) 350-0537 Fax: +1 (626) 454-1667 …See details»
Billing - Fulgent Genetics
Organization Name. Email * Phone Number. Please choose a topic * ... Submit. Contact. [email protected] . Locations. Headquarters. 4399 Santa Anita Ave El Monte, CA …See details»
Executive Team - Fulgent Genetics
Hanlin (Harry) Gao, M.D., Ph.D., D.A.B.M.G., F.A.C.M.G. is a founder of our genetic testing business, has served as Fulgent LLC’s Laboratory Director since February 2012, was …See details»
Senior Management - Fulgent Genetics
She leads the post-M&A integration efforts to standardize and enhance process efficiency across the organization. Before joining Fulgent, she worked at several CROs, Baylor College of …See details»
Fulgent Genetics - LinkedIn
Fulgent Genetics | 11,307 followers on LinkedIn. Our mission is to develop flexible and affordable diagnostics and therapeutics that improve the everyday lives of those around us. Founded in 2011 ...See details»
Fulgent - Overview, News & Similar companies | ZoomInfo.com
Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024 EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the …See details»
How It Works - Fulgent Genetics
[email protected] . Locations. Headquarters. 4399 Santa Anita Ave El Monte, CA 91731 Phone: +1 (626) 350-0537 Fax: +1 (626) 454-1667 . About. About Us Accreditations Contact Us Careers . Products. Genes & Panels …See details»
News Release - Fulgent Genetics
Dec 31, 2021 Full Year 2021 Total Revenue grows 135% year-over-year to $992.6 million; Q4 Revenue totals $251.7 million; Full Year 2021 Core Revenue grows 236% year-over-year to …See details»
Fulgent Genetics - Leader in Next Generation Sequencing
Fulgent is an accredited leader in clinical diagnostic genetic sequencing. Our Exome Sequencing options are patient-centric, phenotype-driven analyses designed to examine coding regions …See details»
Segregation Testing - Fulgent Genetics
[email protected] . Locations. Headquarters. 4399 Santa Anita Ave El Monte, CA 91731 Phone: +1 (626) 350-0537 Fax: +1 (626) 454-1667 . About. About Us Accreditations Contact …See details»
News Release - Fulgent Genetics
Fourth Quarter 2020 Results: Record Revenue of $295.0 million , growing more than 3,400% year-over-year Record Billable tests delivered approximately 3.2 million, approximately 230 …See details»
Fulgent Genetics Acquires Fulgent Pharma, Creating a ... - Business …
Nov 7, 2022 Fulgent Genetics aims to transform from a genomic diagnostic business into a fully integrated precision medicine company focused on oncology. Fulgent Pharma’s proprietary …See details»
News Release - Fulgent Genetics
Jun 16, 2020 Fulgent Genetics has received Emergency Use Authorization from the FDA to provide at-home testing services for SARS-CoV-2, the virus that causes COVID-19 TEMPLE …See details»
Genomic Testing - Fulgent Genetics
[email protected] . Locations. Headquarters. 4399 Santa Anita Ave El Monte, CA 91731 Phone: +1 (626) 350-0537 Fax: +1 (626) 454-1667 . About. About Us Accreditations Contact …See details»
Fulgent Genetics, Inc. (FLGT) Stock Price, News, Quote & History ...
Find the latest Fulgent Genetics, Inc. (FLGT) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Fulgent Genetics Reports First Quarter 2022 Financial Results
May 3, 2022 Revenue totals $320.3 million; Core Revenue excluding COVID-19 NGS testing grows 59% year-over-year to $25.1 million; Raises full year revenue outlook to $660 million …See details»
Reproductive Health Testing | Fulgent Genetics
[email protected] . Locations. Headquarters. 4399 Santa Anita Ave El Monte, CA 91731 Phone: +1 (626) 350-0537 Fax: +1 (626) 454-1667 . About. About Us Accreditations Contact …See details»
Fulgent Genetics Reports Record First Quarter Financial Results ...
First Quarter 2021 Results: Record Revenue of $359.4 million , growing more than 4,500% year-over-year Record Billable tests delivered approximately 3.8 million, or 290 times the volume of …See details»